Mycenax Biotech Inc.


Please enter the company code as 4726 Go to Link

Downstream Process Development

Mycenax provides comprehensive process design and development for downstream process based on our experiences from diverse and complex products. Our in-house technology platforms shorten the time to GMP production and IND submission.

Our Capabilities

  • Development of purification processes including chromatography, tangential flow filtration (TFF), virus filtration steps
  • Optimization of individual purification steps
  • Development of virus removal strategy and conditions
  • Downstream process scale-up
  • Reliable technical transfer, verification and optimization of clients’ downstream processes
  • Process validation activities including scale-down model qualification, resin lifespan study, process characterization
  • Use of Mycenax’ proprietary technology platforms such as MBIFastTM, MBIMicro

Equipment and Technology

  • Chromatography
    • Ion exchange chromatography (IEHPLC)
    • Size exclusion chromatography (SEC)
    • Affinity chromatography using Protein A or Heparin
    • Immobilized metal affinity chromatography (IMAC)
    • Hydrophobic interaction chromatography (HIC)
    • Reverse phase chromatography (RPHPLC)
    • Mixed mode chromatography
  • KR2i semi-automatic TFF system
  • AKTA primeplus, AKTA purifier
  • Filter sizing (nanofiltration, 0.2 micrometer filtration)